Role of Cyclooxygenase-2 for Fluid Secretion by the Inflamed Gallbladder Mucosa

Journal of Gastrointestinal Surgery

Volumn 2, Issue 3, 1998, Pages 269-277

  Nilsson, Bengt ^a   Delbro, Dick ^b   Hedin, Lars ^b   Friman, Styrbjörn ^b   Andius, Stefan ^b   Svanvik, Joar ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; ISOENZYME; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

ANIMAL; ARTICLE; BILE; CAT; CHOLECYSTITIS; COMPARATIVE STUDY; FEMALE; GALLBLADDER; IMMUNOBLOTTING; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILE; CATS; CHOLECYSTITIS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; GALLBLADDER; IMMUNOBLOTTING; INDOMETHACIN; ISOENZYMES; MALE; NITROBENZENES; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES;

EID: 0032057771     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(98)80022-X     Document Type: Article

References (30)

1. Jivegård L, Thornell E, Svanvik J. Fluid secretion by the gallbladder mucosa in experimental cholecystitis is influenced by intramural nerves. Dig Dis Sci 1987;32:1389-1394.
2. 2 formation by the gallbladder in experimental cholecystitis. Gut 1986;27:370-373.
3. Nilsson B, Delbro D, Hedin L, Conradi N, Thune A, Friman S, Wennmalm Å, Yan Z, Svanvik J. Role of nitric oxide in induction of inflammatory fluid secretion by the mucosa of the feline gallbladder. Gastroenterology 1996;110:598-606.
4. Vane JR, Botting RM. New insights into the mode of action of antiinflammatory drugs. Inflamm Res 1995;44:1-10.
5. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 1995;95:1669-1675.
6. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994;90:11693-11697.
7. Vane JR, Botting RM. Mechanism of action of antiinflammatory drugs. Scand J Rheumatol Suppl 1996;102:9-21.
8. Svanvik J, Thornell E, Zettergren L. Gallbladder function in experimental cholecystitis: Reversal of the inflammatory net fluid "secretion" into the gallbladder by indomethacin. Surgery 1981;89:500-506.
9. Parnham MJ. Inflammation 93. Drug News Perspect 1994; 6:737-742.
10. Jivegård L, Thornell E, Björk S, Svanvik J. The effects of morphine and enkephalins on gallbladder function in experimental cholecystitis. Inhibition of inflammatory gallbladder secretion. Scand J Gastroenterol 1985;20:1049-1056.
11. Nilssson B, Friman S, Thune A, Svanvik J. Inflammation reduces mucosal secretion of hydrogen ions and impairs concentrating function and luminal acidification in feline gallbladder. Scand J Gastroenterol 1995;30:1021-1026.
12. Panara MR, Greco A, Santini G, Sciulli MG, Rotondo MT, Padovano R. di-Giamberardino M, Cipollone F, Cuccurullo F, Patrono C, et al. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methane-sulfonamide (NS-398) and 5-methanesulfonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. Br J Pharmacol 1995;116:2429-2434.
13. Thornell E. Mechanism in the development of acute cholecystitis and biliary pain. Scand J Gastroenterol 1982 (Suppl 76), pp 1-78 (thesis).
14. Ring JR, Nguyen DC, Everett LJ. SIS - Spectral index of a sample and SIE - Spectral index of an external standard. In Peng CT, Horrocks DL, Alpen EC, eds. Liquid Scintillation Counting: Recent Application and Development. New York: Academic Press, 1980.
15. Lönnroth C, Svaninger G, Gelin J, Cahlin C, Iresjö B-M, Cvetkovska E, Edström S, Andersson M, Svanberg E, Lundholm K. Effects related to indomethacin prolonged survival and decreased tumor growth in a mouse tumor model with cytokine dependent cancer cachexia. Int J Oncol 1995;7:1405-1413.
16. Piontkewitz Y, Enerbäck S, Hedin L. Expression and hormonal regulation of the CCAAT enhancer binding protein-during differentiation of rat ovarian follicles. Endocrinology 1993;133:2327-2333.
17. Bronstein I, Voyta JC, Murphy OJ, Bresnick L, Kricka LJ. Improved chemiluminescent Western blotting procedure. Biotechniques 1992;12:748-753.
18. Hedin L, Gaddy-Kurten D, Kurten R, DeWitt DL, Smith WL, Richards JS. Prostaglandin endoperoxide synthase in rat ovarian follicles: Content, cellular distribution, and evidence for hormonal induction preceding ovulation. Endocrinology 1987;121:722-731.
19. Wong WYL, Richards JS. Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary. Mol Endocrinol 1991;5:1269-1279.
20. Appleton I, Tomlinson A, Mitchell JA, Willoughby DA. Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future antiinflammatory therapy. J Pathol 1995;176:413-420.
21. 2 affects gallbladder function by activation of intramural nerves in the anaesthetized cat. Acta Physiol Scand 1988;132: 549-555.
22. Nilsson B, Theodorsson E, Jivegård L, Svanvik J. VIP-anti-serum inhibits gallbladder inflammatory fluid secretion in experimental cholecystitis. Regul Peptides 1994;49:179-184.
23. Keast JR, Furness JB, Costa M. Distribution of certain peptide-containing nerve fibers and endocrine cells in the gastrointestinal mucosa in five mammalian species. J Comp Neurol 1985;236:403-422.
24. Shimosegawa T, Abe T, Satoh A, Abe R, Kikuchi Y, Koizumi M, Toyota T. NADPH-diaphorase activity in neurons of the mammalian pancreas: Coexpression with vasoactive intestinal peptide. Gastroenterology 1993;105:999-1008.
25. Dupont C, Broyart JP, Btoer Y, Chenut B, Laburthe M, Rosslin G. Importance of the vasoactive peptide receptor in the stimulation of cyclic adenosine 3′, 5′-monophosphate in gallbladder epithelial cells of man. J Clin Invest 1981;67:742-752.
26. Jansson R, Steen G, Svanvik J. Effects of intravenous vasoactive intestinal polypeptide (VIP) on gallbladder function in the cat. Gastroenterology 1978;75:47-50.
27. Jivegård L, Fahrenkrug J, Svanvik J. Vasoactive intestinal peptide (VIP) in the normal and inflamed gallbladder. Regul peptides 1989;25:179-185.
28. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-7244.
29. Fosterman U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991;42:1849-1857.
30. Engelhardt G. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 1996;35:4-12.